Research Shows CBD Benefits 50+ Conditions by Aaron Cadena at CBD Origin
Over the last few years, Cannabidiol (CBD) has exploded into the world of health and wellness.
With dozens of natural benefits, CBD has been used to ease conditions such as anxiety, epilepsy, neurodegenerative diseases and more.
For the last century, researchers have assessed CBD as a treatment for numerous conditions. More than 50, in fact.
What these studies show is profound.
If you are looking for research on CBD benefits for a certain condition, you will find it here.
From mental health to MS, we have gathered a collection of more than 250 resources, organized by condition.
Check out the collection below and feel free to share your thoughts in the comments below.
Studies Reveal CBD Benefits More Than 50 Conditions
Browse Medical Research Based on Condition
| # | GROUP | CONDITION | MEDICAL RESEARCH |
|---|---|---|---|
| 5 | 1 | CBD FOR ACNE | Cannabidiol as a Treatment for Acne? |
| 1 | CBD FOR ACNE | Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes | |
| 1 | CBD FOR ACNE | The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities | |
| 1 | CBD FOR ACNE | Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling | |
| 1 | CBD FOR ACNE | Endocannabinoid signaling and epidermal differentiation | |
| 6 | 2 | CBD FOR ADD / ADHD | Searching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders |
| 2 | CBD FOR ADD / ADHD | Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats | |
| 2 | CBD FOR ADD / ADHD | Subtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use | |
| 2 | CBD FOR ADD / ADHD | Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students | |
| 2 | CBD FOR ADD / ADHD | Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report | |
| 2 | CBD FOR ADD / ADHD | Fitness to drive in spite (because) of THC | |
| 10 | 3 | CBD FOR ADDICTION | Cannabidiol reduces cigarette consumption in tobacco smokers |
| 3 | CBD FOR ADDICTION | Cannabidiol inhibits the reward-facilitating effect of morphine | |
| 3 | CBD FOR ADDICTION | Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances | |
| 3 | CBD FOR ADDICTION | Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats | |
| 3 | CBD FOR ADDICTION | Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment | |
| 3 | CBD FOR ADDICTION | Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 | |
| 3 | CBD FOR ADDICTION | Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents | |
| 3 | CBD FOR ADDICTION | Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity | |
| 3 | CBD FOR ADDICTION | Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder | |
| 3 | CBD FOR ADDICTION | Cannabidiol for the treatment of cannabis withdrawal syndrome | |
| 4 | 4 | CBD FOR ALS | Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials |
| 4 | CBD FOR ALS | ALS: delayed disease progression in mice by treatment with a cannabinoid | |
| 4 | CBD FOR ALS | The (Endo)Cannabinoid System in Multiple Sclerosis and ALS | |
| 4 | CBD FOR ALS | Survey of cannabis use in patients with ALS | |
| 16 | 5 | CBD FOR ALZHEIMERS | The therapeutic potential of the endocannabinoid system for Alzheimer’s disease |
| 5 | CBD FOR ALZHEIMERS | Endocannabinoid signalling in Alzheimer’s disease | |
| 5 | CBD FOR ALZHEIMERS | A molecular link between the active component of marijuana and Alzheimer’s disease pathology | |
| 5 | CBD FOR ALZHEIMERS | Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells | |
| 5 | CBD FOR ALZHEIMERS | The Potential Therapeutic Effects of THC on Alzheimer’s Disease | |
| 5 | CBD FOR ALZHEIMERS | The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease | |
| 5 | CBD FOR ALZHEIMERS | Cannabinoids for the treatment of dementia | |
| 5 | CBD FOR ALZHEIMERS | Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression | |
| 5 | CBD FOR ALZHEIMERS | Cannabidiol: A promising drug for neurodegenerative disorders? | |
| 5 | CBD FOR ALZHEIMERS | Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition | |
| 5 | CBD FOR ALZHEIMERS | The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses | |
| 5 | CBD FOR ALZHEIMERS | The role of phytochemicals in the treatment and prevention of dementia | |
| 5 | CBD FOR ALZHEIMERS | Cannabinoids for the treatment of dementia | |
| 5 | CBD FOR ALZHEIMERS | Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement | |
| 5 | CBD FOR ALZHEIMERS | Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic | |
| 5 | CBD FOR ALZHEIMERS | Can Marijuana Prevent Alzheimer’s? | |
| 4 | 6 | CBD FOR ANOREXIA | Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa |
| 6 | CBD FOR ANOREXIA | The role of the endocannabinoid system in eating disorders: Neurochemical and behavioural preclinical evidence | |
| 6 | CBD FOR ANOREXIA | Cancer cachexia and cannabinoids | |
| 6 | CBD FOR ANOREXIA | Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa | |
| 9 | 7 | CBD FOR ANXIETY | Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug |
| 7 | CBD FOR ANXIETY | Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa | |
| 7 | CBD FOR ANXIETY | Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients | |
| 7 | CBD FOR ANXIETY | Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder | |
| 7 | CBD FOR ANXIETY | Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation | |
| 7 | CBD FOR ANXIETY | Effects of cannabidiol (CBD) on regional cerebral blood flow | |
| 7 | CBD FOR ANXIETY | The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors | |
| 7 | CBD FOR ANXIETY | The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system | |
| 7 | CBD FOR ANXIETY | Plant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence | |
| 4 | 8 | CBD FOR ATHEROSCLEROSIS | The role of the endocannabinoid system in atherosclerosis |
| 8 | CBD FOR ATHEROSCLEROSIS | Cannabinoid receptors in atherosclerosis | |
| 8 | CBD FOR ATHEROSCLEROSIS | The potential use of cannabidiol in the therapy of metabolic syndrome | |
| 8 | CBD FOR ATHEROSCLEROSIS | Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice | |
| 4 | 9 | CBD FOR ARTHRITIS | Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis |
| 9 | CBD FOR ARTHRITIS | The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis | |
| 9 | CBD FOR ARTHRITIS | The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 | |
| 9 | CBD FOR ARTHRITIS | Arthritis and cannabinoids | |
| 5 | 10 | CBD FOR ASTHMA | The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke |
| 10 | CBD FOR ASTHMA | Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma | |
| 10 | CBD FOR ASTHMA | Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs | |
| 10 | CBD FOR ASTHMA | Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways | |
| 10 | CBD FOR ASTHMA | Bronchodilator effect of delta1-tetrahydrocannabinol | |
| 5 | 11 | CBD FOR AUTISM | Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain |
| 11 | CBD FOR AUTISM | Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders | |
| 11 | CBD FOR AUTISM | A novel approach to the symptomatic treatment of autism | |
| 11 | CBD FOR AUTISM | Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders | |
| 11 | CBD FOR AUTISM | Targeting the endocannabinoid system in the treatment of fragile X syndrome | |
| 5 | 12 | CBD FOR BIPOLAR AFFECTIVE DISORDER | Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential |
| 12 | CBD FOR BIPOLAR AFFECTIVE DISORDER | Cannabidiol was ineffective for manic episode of bipolar affective disorder | |
| 12 | CBD FOR BIPOLAR AFFECTIVE DISORDER | Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania | |
| 12 | CBD FOR BIPOLAR AFFECTIVE DISORDER | Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis | |
| 12 | CBD FOR BIPOLAR AFFECTIVE DISORDER | The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research | |
| 5 | 13 | CBD FOR CANCER - GENERAL | Cannabidiol as potential anticancer drug |
| 13 | CBD FOR CANCER - GENERAL | Cannabidiol inhibits angiogenesis by multiple mechanisms | |
| 13 | CBD FOR CANCER - GENERAL | The inhibitory effects of cannabidiol on systemic malignant tumors | |
| 13 | CBD FOR CANCER - GENERAL | Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 | |
| 13 | CBD FOR CANCER - GENERAL | Marijuana fights cancer and helps manage side effects | |
| 4 | 14 | CBD FOR CANCER - LUNG | Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1C |
| 14 | CBD FOR CANCER - LUNG | COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells | |
| 14 | CBD FOR CANCER - LUNG | Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells | |
| 14 | CBD FOR CANCER - LUNG | Media ignored expert’s shocking findings that marijuana helps prevent lung cancer | |
| 5 | 15 | CBD FOR CANCER - PROSTATE/COLON | Towards the use of non-psychoactive cannabinoids for prostate cancer |
| 15 | CBD FOR CANCER - PROSTATE/COLON | In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines | |
| 15 | CBD FOR CANCER - PROSTATE/COLON | Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent | |
| 15 | CBD FOR CANCER - PROSTATE/COLON | Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer | |
| 15 | CBD FOR CANCER - PROSTATE/COLON | Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol | |
| 5 | 16 | CBD FOR CANCER - BREAST | Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma |
| 16 | CBD FOR CANCER - BREAST | Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy | |
| 16 | CBD FOR CANCER - BREAST | Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis | |
| 16 | CBD FOR CANCER - BREAST | Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells | |
| 16 | CBD FOR CANCER - BREAST | Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration | |
| 8 | 17 | CBD FOR CANCER - BRAIN | Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival |
| 17 | CBD FOR CANCER - BRAIN | Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed) | |
| 17 | CBD FOR CANCER - BRAIN | Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas | |
| 17 | CBD FOR CANCER - BRAIN | Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism | |
| 17 | CBD FOR CANCER - BRAIN | Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target | |
| 17 | CBD FOR CANCER - BRAIN | Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents | |
| 17 | CBD FOR CANCER - BRAIN | Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect | |
| 17 | CBD FOR CANCER - BRAIN | Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme | |
| 4 | 18 | CBD FOR CANCER - LEUKEMIA | Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression |
| 18 | CBD FOR CANCER - LEUKEMIA | Cannabidiol-Induced Apoptosis in Human Leukemia Cells | |
| 18 | CBD FOR CANCER - LEUKEMIA | Cannabidiol Reduces Leukemic Cell Size – But Is It Important? | |
| 18 | CBD FOR CANCER - LEUKEMIA | Targeting cannabinoid receptors to treat leukemia | |
| 4 | 19 | CBD FOR CANCER - SKIN | Anticancer activity of anandamide in human cutaneous melanoma cells |
| 19 | CBD FOR CANCER - SKIN | Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium (PubMed) | |
| 19 | CBD FOR CANCER - SKIN | Cannabinoid receptors as novel targets for the treatment of melanoma | |
| 19 | CBD FOR CANCER - SKIN | The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development | |
| 4 | 20 | CBD FOR CANCER - ENDOCRINE | Endocannabinoids in endocrine and related tumours |
| 20 | CBD FOR CANCER - ENDOCRINE | A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells | |
| 20 | CBD FOR CANCER - ENDOCRINE | Cannabinoids in pancreatic cancer: Correlation with survival and pain | |
| 20 | CBD FOR CANCER - ENDOCRINE | Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma | |
| 4 | 21 | CBD FOR CANCER - BLADDER | TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer |
| 21 | CBD FOR CANCER - BLADDER | Association Between Cannabis Use and the Risk of Bladder Cancer | |
| 21 | CBD FOR CANCER - BLADDER | Inhibitory Effect of Standardized Cannabis sativaExtract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility | |
| 21 | CBD FOR CANCER - BLADDER | Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism | |
| 4 | 22 | CBD FOR CANCER - PAIN RELIEF | Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain |
| 22 | CBD FOR CANCER - PAIN RELIEF | Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial | |
| 22 | CBD FOR CANCER - PAIN RELIEF | Marijuana extract helps prevent chemo pain | |
| 22 | CBD FOR CANCER - PAIN RELIEF | An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics | |
| 10 | 23 | CBD FOR CROHNS & COLITIS | Cannabidiol in inflammatory bowel diseases: a brief overview |
| 23 | CBD FOR CROHNS & COLITIS | Cannabis finds its way into treatment of Crohn’s disease | |
| 23 | CBD FOR CROHNS & COLITIS | Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis | |
| 23 | CBD FOR CROHNS & COLITIS | Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis | |
| 23 | CBD FOR CROHNS & COLITIS | The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis | |
| 23 | CBD FOR CROHNS & COLITIS | Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice | |
| 23 | CBD FOR CROHNS & COLITIS | Cannabinoids and the gut: New developments and emerging concepts | |
| 23 | CBD FOR CROHNS & COLITIS | Endocannabinoids and the gastrointestinal tract | |
| 23 | CBD FOR CROHNS & COLITIS | Cannabinoids and gastrointestinal motility: Animal and human studies | |
| 23 | CBD FOR CROHNS & COLITIS | Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis | |
| 11 | 24 | CBD FOR DEPRESSION | Endocannabinoid system dysfunction in mood and related disorders |
| 24 | CBD FOR DEPRESSION | Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa | |
| 24 | CBD FOR DEPRESSION | The endocannabinoid system and the treatment of mood and anxiety disorders | |
| 24 | CBD FOR DEPRESSION | Endocannabinoid signaling in the etiology and treatment of major depressive illness | |
| 24 | CBD FOR DEPRESSION | Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors | |
| 24 | CBD FOR DEPRESSION | Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants | |
| 24 | CBD FOR DEPRESSION | Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa | |
| 24 | CBD FOR DEPRESSION | Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress | |
| 24 | CBD FOR DEPRESSION | Serum contents of endocannabinoids are correlated with blood pressure in depressed women | |
| 24 | CBD FOR DEPRESSION | The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants | |
| 24 | CBD FOR DEPRESSION | Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures | |
| 21 | 25 | CBD FOR ENDOCRINE DISORDERS | Endocannabinoid system participates in neuroendocrine control of homeostasis |
| 25 | CBD FOR ENDOCRINE DISORDERS | The emerging role of the endocannabinoid system in endocrine regulation and energy balance | |
| 25 | CBD FOR ENDOCRINE DISORDERS | Endocannabinoids in endocrine and related tumours | |
| 25 | CBD FOR ENDOCRINE DISORDERS | Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas | |
| 25 | CBD FOR ENDOCRINE DISORDERS | The role of the endocannabinoid system in the neuroendocrine regulation of energy balance | |
| 25 | CBD FOR ENDOCRINE DISORDERS | CBD for children with Dravet’s and intractable seizures | |
| 25 | CBD FOR ENDOCRINE DISORDERS | Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy | |
| 25 | CBD FOR ENDOCRINE DISORDERS | Medicinal marijuana stops seizures, brings hope to a little girl | |
| 25 | CBD FOR ENDOCRINE DISORDERS | Cannabinoids for epilepsy | |
| 25 | CBD FOR ENDOCRINE DISORDERS |
This post first appeared on My CBD Coupons | Save More On The Best CBD Brands & Products, please read the originial post: here
